Q3 2026 13F · SEC CIK 1830922
Chiron Capital Management, LLC
Wealth managerFiled 2026-10-15 for Q3 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $100.6M
- Reported positions
- 125
- Top holdings a year, 3 yrs
- +6.5%
- Assets under management
- $242.6M
Chiron Capital Management, LLC is a wealth manager that reported 125 positions worth $100.6M in its Q3 2026 13F, filed 2026-10-15. Its largest holdings were Bristol-Myers Squibb Co (BMY, 10.9%), Nvidia Corporation (NVDA, 6.1%), Microsoft Corp (MSFT, 3.5%). A portfolio copying its top holdings returned 6.5% a year over the last 3 years, against 20.4% for the S&P 500.
Chiron Capital Management, LLC holdings largest 50 of 125 positions.
Weights are shares of the filer's total reported 13F value, compared with Q2 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
What Chiron Capital Management, LLC bought and sold in Q3 2026, against Q2 2026.
New positions
Q2 2026's filing was too long to tell new positions apart.
Added to
- PEP Pepsico Inc+34.1% shares
- KMB Kimberly-Clark Corp+30.9% shares
- OTIS Otis Worldwide Corp+26.2% shares
- LEN Lennar Corp+15.7% shares
- VZ Verizon Communications Inc+8.8% shares
- BSX Boston Scientific Corp+8.4% shares
Reduced
- CRM Salesforce Inc-60.1% shares
- PFE Pfizer Inc-50.7% shares
- UNH Unitedhealth Group Inc-45.9% shares
- SAPGF Sap SE-38.4% shares
- TSLA Tesla Inc-37.2% shares
- MSFT Microsoft Corp-34.8% shares
- ADBE Adobe Inc-34.5% shares
- PYPL Paypal Hldgs Inc-30.0% shares
Left the top 50
- BDX Becton Dickinson & Cowas 1.4%
- DHR Danaher Corp Delwas 1.0%
- VOO Vanguard Index Fdswas 0.9%
- TDOC Teladoc Health Incwas 0.8%
- TMO Thermo Fisher Scientific Incwas 0.8%
- TEAM Atlassian Corporationwas 0.8%
- MKC Mccormick & Co Incwas 0.7%
- MDT Medtronic PLCwas 0.7%
Share counts compared with the Q2 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.
How the holdings did against the S&P 500.
- 1 year
- +15.3% /yr
- S&P 500 +20.1%
- 3 years
- +6.5% /yr
- S&P 500 +20.4%
- 5 years
- +4.5% /yr
- S&P 500 +11.6%
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q3 2026 | $100.6M | 125 |
| Q2 2026 | $111.5M | 136 |
| Q1 2026 | $97.5M | 117 |
| Q3 2025 | $116.8M | 122 |
| Q2 2025 | $114.9M | 119 |
| Q1 2025 | $110.0M | 114 |
| Q4 2024 | $105.9M | 113 |
| Q3 2024 | $113.0M | 119 |
| Q2 2024 | $104.7M | 113 |
| Q1 2024 | $110.1M | 108 |
| Q4 2023 | $114.9M | 117 |
| Q3 2023 | $116.3M | 112 |
Questions about Chiron Capital Management, LLC's portfolio
What stocks does Chiron Capital Management, LLC own?
Chiron Capital Management, LLC's latest 13F, for Q3 2026 and filed Oct 15, 2026, lists 125 positions worth $100.6M. The largest are Bristol-Myers Squibb Co (BMY) at 10.9%, Nvidia Corporation (NVDA) at 6.1%, Microsoft Corp (MSFT) at 3.5%, Apple Inc (AAPL) at 3.4% and Aflac Inc (AFL) at 2.6%.
What did Chiron Capital Management, LLC buy last quarter?
In Q3 2026, Chiron Capital Management, LLC added Pepsico Inc (PEP) (+34.1% shares), Kimberly-Clark Corp (KMB) (+30.9% shares) and Otis Worldwide Corp (OTIS) (+26.2% shares), compared with its Q2 2026 filing.
What did Chiron Capital Management, LLC sell last quarter?
In Q3 2026, Chiron Capital Management, LLC cut from its top 50 Becton Dickinson & Co (BDX), cut from its top 50 Danaher Corp Del (DHR), cut from its top 50 Vanguard Index Fds (VOO), cut from its top 50 Teladoc Health Inc (TDOC), cut from its top 50 Thermo Fisher Scientific Inc (TMO), Salesforce Inc (CRM) (-60.1% shares), Pfizer Inc (PFE) (-50.7% shares) and Unitedhealth Group Inc (UNH) (-45.9% shares), compared with its Q2 2026 filing.
How has Chiron Capital Management, LLC's portfolio performed?
A portfolio copying Chiron Capital Management, LLC's 20 largest 13F holdings each quarter, from the day each filing was public, returned +6.5% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +15.3% against +20.1%. Over 5 years: +4.5% a year against +11.6%.
When is Chiron Capital Management, LLC's next 13F filing due?
13F filings are due 45 days after each quarter ends. Chiron Capital Management, LLC's filing for the quarter ending Dec 31, 2026 is due by Feb 14, 2027; this page updates the day after it is published.
How much money does Chiron Capital Management, LLC manage?
Chiron Capital Management, LLC reported $242.6M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $100.6M.